Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Mrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.
Journal for Immunotherapy of Cancer
|
April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
Evan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2024
Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C
Mark H O'Hara, Opeyemi Jegede, Mark A Dickson, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
The Oncologist
|
May 30, 2013
Ipilimumab for patients with advanced mucosal melanoma
Michael A Postow, Jason J Luke, Mark J Bluth, et al.
The Oncologist
|
October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
Rodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Mrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.
Journal for Immunotherapy of Cancer
|
April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
Evan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2024
Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C
Mark H O'Hara, Opeyemi Jegede, Mark A Dickson, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
The Oncologist
|
May 30, 2013
Ipilimumab for patients with advanced mucosal melanoma
Michael A Postow, Jason J Luke, Mark J Bluth, et al.
The Oncologist
|
October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
Rodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, et al.
Page
of 8